CCL11 and neoplasm: Collectively, these results suggest that CD8 + T and NK cells are necessary for the tumor inhibition and eradication induced by CCL11-E6E7 immunotherapy and CD4 + T-cell help the expansion of specific CD8 + T cells and durable remission.